406 related articles for article (PubMed ID: 11692897)
1. Role of ultrasonography and urinary cytology in diagnosing recurrence of superficial urinary bladder cancer compared to cystoscopy.
Roy MK; Islam MF; Kibria SA
Bangladesh Med Res Counc Bull; 2001 Apr; 27(1):23-32. PubMed ID: 11692897
[TBL] [Abstract][Full Text] [Related]
2. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
Kumar A; Kumar R; Gupta NP
Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
[TBL] [Abstract][Full Text] [Related]
3. Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder.
Sawczuk IS; Bagiella E; Sawczuk AT; Yun EJ
Cancer Detect Prev; 2000; 24(4):364-8. PubMed ID: 11059567
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
Jancke G; Damm O; Rosell J; Jahnson S
Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
[TBL] [Abstract][Full Text] [Related]
5. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
6. Superficial bladder tumours: recurrence and progression.
Mansoor M; Ali S; Fasihuddin Q; Baloch MU
J Coll Physicians Surg Pak; 2011 Mar; 21(3):157-60. PubMed ID: 21419022
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of transitional cell carcinoma of the bladder in childhood.
Bujons A; Caffaratti J; Garat JM; Villavicencio H
J Pediatr Urol; 2014 Feb; 10(1):167-70. PubMed ID: 24035638
[TBL] [Abstract][Full Text] [Related]
8. [Can the combination of bladder ultrasonography and urinary cytodiagnosis replace cystoscopy in the diagnosis and follow-up of tumors of the bladder?].
Cariou G; Maaraoui N; Cortesse A
Prog Urol; 1997 Feb; 7(1):51-5. PubMed ID: 9116739
[TBL] [Abstract][Full Text] [Related]
9. HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer--re-TURBT recurrence rates in a prospective, randomized study.
Geavlete B; Jecu M; Multescu R; Georgescu D; Geavlete P
Urology; 2010 Sep; 76(3):664-9. PubMed ID: 20627289
[TBL] [Abstract][Full Text] [Related]
10. [Suprapubic bladder ultrasonography and urinary cytology: indications and limits in the follow-up of superficial bladder tumors].
Pegoraro C; Bondavalli C; Molani L; Capitanio A; Schiavon L; Dall'Oglio B; Luciano M; Negri S
Arch Ital Urol Nefrol Androl; 1991 Jun; 63 Suppl 2():127-9. PubMed ID: 1836650
[TBL] [Abstract][Full Text] [Related]
11. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
[TBL] [Abstract][Full Text] [Related]
12. Role of low-mechanical index CEUS in the differentiation between low and high grade bladder carcinoma: a pilot study.
Drudi FM; Cantisani V; Liberatore M; Iori F; Erturk SM; Cristini C; Di Pierro G; D'Ambrosio U; Malpassini F; De Felice C; Di Leo N
Ultraschall Med; 2010 Dec; 31(6):589-95. PubMed ID: 20449795
[TBL] [Abstract][Full Text] [Related]
13. Can transabdominal ultrasonography of the bladder replace cystoscopy in the followup of superficial bladder tumors?
Vallancien G; Veillon B; Charton M; Brisset JM
J Urol; 1986 Jul; 136(1):32-4. PubMed ID: 3520026
[TBL] [Abstract][Full Text] [Related]
14. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
[TBL] [Abstract][Full Text] [Related]
15. The efficiency of excretory urography to detect upper urinary tract tumors after cystectomy for urothelial cancer.
Meissner C; Giannarini G; Schumacher MC; Thoeny H; Studer UE; Burkhard FC
J Urol; 2007 Dec; 178(6):2287-90. PubMed ID: 17936846
[TBL] [Abstract][Full Text] [Related]
16. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
17. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
18. The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer--institutional experience and review.
Önal B; Han Ü; Yilmaz S; Köybasioglu F; Altuğ U
Diagn Cytopathol; 2015 Apr; 43(4):307-14. PubMed ID: 25488052
[TBL] [Abstract][Full Text] [Related]
19. High-grade transitional cell carcinoma of the pediatric bladder.
Korrect GS; Minevich EA; Sivan B
J Pediatr Urol; 2012 Jun; 8(3):e36-8. PubMed ID: 22105002
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of semaphorin 3A in patients with urothelial cancer.
Vadasz Z; Rubinstein J; Bejar J; Sheffer H; Halachmi S
Urol Oncol; 2018 Apr; 36(4):161.e1-161.e6. PubMed ID: 29288007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
